Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer

Combination antiprogrammed death 1/programmed death‐ligand 1 Ab and platinum‐based chemotherapy is standard first‐line treatment for advanced non‐small‐cell lung cancer without targetable oncogene alterations. We describe the long‐term safety and efficacy data from a previously reported phase Ib stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Shintaro, Ohe, Yuichiro, Goto, Yasushi, Horinouchi, Hidehito, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Yamamoto, Takanori, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293099/
https://www.ncbi.nlm.nih.gov/pubmed/32277531
http://dx.doi.org/10.1111/cas.14410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293099/
https://www.ncbi.nlm.nih.gov/pubmed/32277531
http://dx.doi.org/10.1111/cas.14410

Ejemplares similares